CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Vanda Pharmaceuticals (VNDA) Reports Q2 Loss, Lags Revenue Estimates

EarningsNegative
AI Analysis

Summary

Vanda Pharmaceuticals reported a Q2 net loss and missed revenue estimates, indicating operational challenges for the company.

Importance:3/10
Sentiment:
-0.60
earningsQ2 2026revenue missnet loss
Related Companies

Read the original article

Published by yahoo_finance on August 5, 2026 9:10 PM

Read Original